Protalix BioTherapeutics (DE) Statistics
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.71-0.02 (-0.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.66 -1.85%
Protalix BioTherapeutics (DE) by the numbers
Protalix BioTherapeutics (DE) has a market capitalization of $218.3 million based on 80.57M shares outstanding. Its trailing P/E ratio is 11.8, and its forward P/E is 4.4. The stock trades 6.2% above its 50-day average and 15.6% above its 200-day average.
Average daily trading volume is 729.36K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PLX valuation vs. peer median
| Metric | PLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $218.35M | $223.27M | -2% |
| Avg. volume | 729.36K | 1.52M | -52% |
Peer median across 8 companies: IVVD, ALEC, IPSC, CGEN, LCTX, STRO, CMPX, FATE.
Valuation
- Market cap
- $218.35M
- P/E (TTM)
- 11.78
- Forward P/E
- 4.37
- EPS (TTM)
- $0.23
- Shares outstanding
- 80.57M
Price and trading
- Previous close
- 2.73
- Open
- 2.70
- Day range
- 2.70 – 2.76
- 52-week range
- 1.60 – 3.19
- 52-week change
- +8.40%
- Beta
- —
- Volume
- 794.48K
- Average volume
- 729.36K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 218.35M
- Pe
- 11.78
- Forward Pe
- 4.37
- Eps
- 0.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.19
- Week52 Low
- 1.60
- Avg Volume
- 729.36K
- Shares Outstanding
- 80.57M
- Ma50
- 2.55
- Ma200
- 2.34
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -15.05%
- Pct From52w Low
- 69.37%